epilepsy
GW Pharma’s cannabis-based Epidyolex edges closer to EU approval with positive CHMP opinion in epilepsy
July 26, 2019Medical Communications, Sales and Marketing EMA, Epidiolex, Europe, GW Pharma, cannabis, epilepsy
UK-based biotech GW Pharmaceuticals has announced that its cannabidiol oral solution Epidyolex has secured recommendation from the European Medicines Agency’s …
Pfizer’s Lyrica fails at Phase 3 in treating primary generalised tonic-clonic (PGTC) seizures
May 28, 2019Manufacturing and Production, Research and Development, Sales and Marketing Lyrica, Pfizer, epilepsy, pharma, trial failure
Pfizer has unveiled new Phase 3 data on the effectiveness of Lyrica (pregabalin) in the adjunctive treatment of primary generalised …
GW Pharma’s Epidiolex scores in rare childhood onset epilepsy Phase 3 trial
May 7, 2019Manufacturing and Production, Sales and Marketing CBD, Epidiolex, GW Pharma, cannabidiol, cannabis, epilepsy, tsc
GW Pharma’s Epidiolex has shown positive Phase 3 trial results for the fifth time in a row, after meeting primary …
Epilepsy Society calls for review of UK supply chain following “steep rise” in access issues
April 9, 2019Manufacturing and Production, Sales and Marketing Epilepsy Society, UK, brexit, epilepsy, market access, pharma
The Epilepsy Society has drawn attention to the “steep rise” in UK patients who are encountering difficulty in accessing seizure …
Antiepileptics increase the risk of pneumonia in people with Alzheimer’s disease
March 21, 2019Research and Development Alzheimer's, R&D, adverse events, antiepileptic drugs, epilepsy, pneumonia
Antiepileptic drugs increase the risk of pneumonia in people living with Alzheimer’s disease, according to research from the University of …
UCB teams up with charity to beat treatment-resistant epilepsy in $2.5m partnership
February 11, 2019Research and Development, Sales and Marketing Epilepsy Society, UCB Pharma, epilepsy, pharma
Belgian firm UCB Pharma has announced a new partnership with the charity Epilepsy Society which will see the pair invest …
Pfizer’s Lyrica achieves endpoint as adjunct in paediatric epilepsy
May 18, 2018Medical Communications, Research and Development FDA, Lyrica, Pfizer, epilepsy, pharma
Pfizer has revealed new Phase 3 data for its oral epilepsy therapy Lyrica (pregbalin) as an adjunctive treatment for partial …
MHRA bans sodium valproate in the UK following birth defect controversy
April 24, 2018Manufacturing and Production, Research and Development, Sales and Marketing MHRA, Sanofi, Sodium valproate, bipolar, epilepsy, pharma
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced that sodium valproate, a drug used in the treatment …
Antiepileptic drug use linked to increased risk of Alzheimer’s and dementia
April 10, 2018Manufacturing and Production, Research and Development Alzheimer's disease, dementia, epilepsy, pharma
A new study conducted at the University of Eastern Finland and the German Center for Neurodegenerative Diseases (DZNE) has revealed …
Real-world data prove efficacy of Eisai and Bial’s epilepsy treatment
September 6, 2017Research and Development Bial, Eisai, Zebinix, epilepsy, pharma
Bial and Eisai have released real-world data which support the efficacy of Zebinix (eslicarbazepine acetate) in the treatment of partial-onset …
Cannabidiol drug found to aid in devastating childhood epilepsy condition
May 25, 2017Research and Development GW Pharmaceuticals, cannabidoil, epilepsy
A treatment derived from cannabis has been found to produce remarkable results in children who have epilepsy. Cannabidoil, when offered …
European approval for novel Eisai epilepsy monotherapy
May 23, 2017Research and Development, Sales and Marketing Bial, Eisai, Zebinix, epilepsy
Eisai and Bial have revealed that their drug Zebinix (eslicarbazepine acetate) has been awarded marketing authorisation by the European Commission …
Love it or hate it – Vitamin B12 may give the brain a boost
April 13, 2017Research and Development Marmite, anxiety, epilepsy
Trying to explain to someone outside of the UK or Australia and New Zealand what Marmite is can be a …
Eisai reveals new long-term seizure control data at ECE 2016
September 13, 2016Manufacturing and Production, Research and Development Eisai, epilepsy
Eisai has revealed new data on long-term seizure control in different seizure types at the 12th European Congress on Epileptology …
GW Pharma’s cannabis-based epilepsy drug granted orphan designation by FDA
April 21, 2016Research and Development, Sales and Marketing GW Pharma, cannabis, cannabis-based, epilepsy
GW Pharmaceuticals (NASDAQ: GWPH) has announced that the US Food and Drug Administration has granted its cannabis-based epilepsy drug, Epidiolex …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
